ERA Congress: Semaglutide linked to better quality of life in diabetes and kidney disease, FLOW trial shows

Details werden geladen...

https://www.manilatimes.net/2026/06/04/tmt-newswire/pr-newswire/era-congress-semaglutide-linked-to-better-quality-of-life-in-diabetes-and-kidney-disease-flow-trial-shows/2358351

Teilen bei Facebook
Teilen bei Twitter
Teilen bei Pinterest
Per Mail empfehlen

ERA Congress: Semaglutide linked to better quality of life in diabetes and kidney disease, FLOW trial shows | The Manila Times

GLASGOW, Scotland, June 4, 2026 /PRNewswire/ -- New findings from the landmark FLOW trial, presented at the 63rd ERA Congress, show that once-weekly semaglutide significantly improved health-related quality of life in adults with type 2 diabetes (T2D) and chronic kidney disease (CKD), equivalent to around eight additional days in full health per year.

ERA Congress: Semaglutide linked to better quality of life in diabetes and kidney disease, FLOW trial shows

https://www.finanznachrichten.de/nachrichten-2026-06/68675342-era-congress-semaglutide-linked-to-better-quality-of-life-in-diabetes-and-kidney-disease-flow-trial-shows-008.htm

Registrieren

ERA Congress: Semaglutide linked to better quality of life in diabetes and kidney disease, FLOW trial shows | The Manila Times

Ähnliche Seiten

ERA Congress: Semaglutide linked to better quality of life in diabetes and kidney disease, FLOW trial shows